This document provides guidelines for how to develop and implement a software change control system to manage all changes made during three-dimensional (3D) printing of medical products to create tissues or tissue-like structures (bioprinting) for transplantation into an animal or human, and/or anatomic modeling purposes. The change control system will provide a process to ensure that the changes made to the product are introduced in a controlled manner.
- Sponsor Committee
- EMB/Stds Com - Standards Committee
Learn More About EMB/Stds Com - Standards Committee - Status
- Active PAR
- PAR Approval
- 2020-03-05
Working Group Details
- Society
- IEEE Engineering in Medicine and Biology Society
Learn More About IEEE Engineering in Medicine and Biology Society - Sponsor Committee
- EMB/Stds Com - Standards Committee
Learn More About EMB/Stds Com - Standards Committee - Working Group
-
3D-B TEMPs - Three-Dimensional (3D) Bioprinting of Tissue-Engineered Medical Products (TEMPs)
Learn More About 3D-B TEMPs - Three-Dimensional (3D) Bioprinting of Tissue-Engineered Medical Products (TEMPs) - IEEE Program Manager
- Malia Zaman
Contact Malia Zaman - Working Group Chair
- Lexi Garcia
Other Activities From This Working Group
Current projects that have been authorized by the IEEE SA Standards Board to develop a standard.
No Active Projects
Standards approved by the IEEE SA Standards Board that are within the 10-year lifecycle.
No Active Standards
These standards have been replaced with a revised version of the standard, or by a compilation of the original active standard and all its existing amendments, corrigenda, and errata.
No Superseded Standards
These standards have been removed from active status through a ballot where the standard is made inactive as a consensus decision of a balloting group.
No Inactive-Withdrawn Standards
These standards are removed from active status through an administrative process for standards that have not undergone a revision process within 10 years.
No Inactive-Reserved Standards